| 698268 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin – A Promising Natural Lead for New Drug Discovery and Development |
2021-06-01 |
10.2147/dddt.s299753 |
Muhamad Fadzil Nur Sakinah, Sekar Mahendran, Gan Siew Hua, Bonam Srinivasa Reddy, Wu Yuan Seng, Vaijanathappa Jaishree, Ravi Subban, Lum Pei Teng, Dhadde Shivsharan B |
| 698267 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats |
2021-06-01 |
10.2147/dddt.s307257 |
Zou Wenlan, Zhang Chen, Gu Xuefang, Li Xiaohong, Zhu Huiming |
| 698266 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [68Ga] IPCAT-NOTA as an Imaging Agent for Dopamine Transporter |
2021-06-01 |
10.2147/dddt.s288600 |
Farn Shiou-Shiow, Chang Kang-Wei, Lin Wan-Chi, Yu Hung-Man, Lin Kun-Liang, Tseng Yu-Chin, Chang Yu, Yu Chung-Shan, Lin Wuu-Jyh |
| 698265 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles |
2021-06-01 |
10.2147/dddt.s314361 |
Zheng Kangyu, Huang Zeju, Huang Jiaying, Liu Xiangmei, Ban Junfeng, Huang Xin, Luo Haosen, Chen Zhicong, Xie Qingchun, Chen Yanzhong, Lu Zhufen |
| 698264 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration |
2021-06-01 |
10.2147/dddt.s295223 |
Hussain Rehan M, Shaukat Bilal A, Ciulla Lauren M, Berrocal Audina M, Sridhar Jayanth |
| 698263 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer |
2021-06-01 |
10.2147/dddt.s281599 |
Chilà Giovanna, Guarini Vincenzo, Galizia Danilo, Geuna Elena, Montemurro Filippo |
| 698262 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China |
2021-06-01 |
10.2147/dddt.s313714 |
Wu Xingbing, Huang Chen, Wang Hui, Ji Jinru, Ying Chaoqun, Xiao Yonghong |
| 698261 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Progress in Redirecting Antiparasitic Drugs for Cancer Treatment |
2021-06-01 |
10.2147/dddt.s308973 |
Huang Haoyang, He Qing, Guo Binghua, Xu Xudong, Wu Yinjuan, Li Xuerong |
| 698260 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Factors Associated with Benzodiazepines Prolonged-Term Use in Post-Stroke Subjective Sleep Disturbance: A Single-Centre Retrospective Study from China |
2021-06-01 |
10.2147/dddt.s298552 |
Ma Guozhong, Sun Liuqing, Qie Zhiwei, He Jinzhao, Cui Fang |
| 698259 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Metformin Decreases Insulin Resistance in Type 1 Diabetes Through Regulating P53 and RAP2A in vitro and in vivo [Retraction] |
2021-06-01 |
10.2147/dddt.s322990 |
Ren Gao-Fei, Xiao Li-Li, Ma Xiao-Jun, Yan Yu-Shan, Jiao Peng-Fei |
